ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
93.94
1.58
( 1.71% )
Updated: 07:59:04

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
93.94
Bid
93.93
Ask
93.95
Volume
265,167
92.79 Day's Range 94.33
80.60 52 Week Range 104.32
Market Cap
Previous Close
92.36
Open
93.20
Last Trade
13
@
93.94
Last Trade Time
07:58:50
Financial Volume
-
VWAP
-
Average Volume (3m)
1,484,394
Shares Outstanding
1,252,640,466
Dividend Yield
8.01%
PE Ratio
21.87
Earnings Per Share (EPS)
4.31
Revenue
43.07B
Net Profit
5.4B

About Sanofi

Sector
Health & Allied Services,nec
Industry
Pharmaceutical Preparations
Website
Headquarters
Paris, Paris, Fra
Founded
1994
Sanofi is listed in the Health & Allied Services sector of the Euronext with ticker SAN. The last closing price for Sanofi was 92.36 €. Over the last year, Sanofi shares have traded in a share price range of 80.60 € to 104.32 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 115.69 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.87.

SAN Latest News

Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A

   NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A ALTUVIIIO provides high-sustained factor...

Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints d’hémophilie A sévère

Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints...

Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD

Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD...

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne Dupixent devient le tout premier médicament ciblé pour...

Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans

Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans...

Press Release: Availability of the Q2 2024 Aide-mémoire

Press Release: Availability of the Q2 2024 Aide-mémoire Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on...

Communiqué de presse : Audrey Duval Derveloy nommée Directrice Affaires Corporate Groupe, membre du Comité exécutif de Sanofi

Communiqué de presse : Audrey Duval Derveloy nommée Directrice Affaires Corporate Groupe, membre du Comité exécutif de Sanofi Audrey Duval Derveloy nommée Directrice Affaires Corporate...

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.030.031945479714693.9194.3390.73120263292.19915345DE
45.96.7014993184988.0494.9187.53143462191.57856397DE
122.282.4874536329991.6694.9185.94148439490.51694693DE
260.230.2454380535793.7194.9184.93144280089.52601039DE
52-4.99-5.0439704841898.93104.3280.6146095991.38323891DE
1566.947.9770114942587106.6676.45178134191.37036362DE
26018.9425.253333333375106.6667.65201001888.07411886DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 10.59
(40.26%)
18.49M
NCPLNetcapital Inc
$ 0.1383
(32.98%)
22.91M
RRRichtech Robotics Inc
$ 1.95
(32.65%)
8.88M
DBVTDBV Technologies SA
$ 1.04
(23.81%)
49.6k
CISOCISO Global Inc
$ 0.7105
(19.41%)
1.67M
HUBCWHub Cyber Security Ltd
$ 0.0121
(-47.39%)
1.65k
XCURExicure Inc
$ 0.3902
(-27.08%)
201.46k
VVOSVivos Therapeutics Inc
$ 2.05
(-16.33%)
1
RYAAYRyanair Holdings PLC
$ 98.04
(-14.24%)
37.5k
SNTGSentage Holdings Inc
$ 2.14
(-13.71%)
21.08k
NCPLNetcapital Inc
$ 0.1383
(32.98%)
22.91M
SERVServe Robotics Inc
$ 10.59
(40.26%)
18.49M
RRRichtech Robotics Inc
$ 1.95
(32.65%)
8.88M
MAXNMaxeon Solar Technologies Ltd
$ 0.225
(4.36%)
3.24M
SQQQProShares UltraPro Short QQQ
$ 8.23
(-2.72%)
3.02M

Discussion

View Full Feed
PROPHET-of-PROFITS PROPHET-of-PROFITS 38 seconds ago
This starts to move on low volume it'll be a monster
IDVV
LVerstee LVerstee 1 minute ago
Pushing is necessary only when delays occur, and you have acknowledged that delays are present.

I will have my contact check with the option whether direct communication with me is possible. That way I cab get to understand the misunderstandings you mentioned and to determine if they
ITUP
J.T. Marlin J.T. Marlin 2 minutes ago
BOOM!!!!
CTM
bananarama bananarama 2 minutes ago
Production continues to expand! This is the key. What sellers are missing is the fact that in order for KBLB to attain earnings and all of the other great milestones like contract announcements and the great SS clothing reveal, we must complete our production goals and expansion. Kim and Jon are d
KBLB
Heisgreater Heisgreater 3 minutes ago
I appreciate the company giving us weekly updates and this one continues to encourage me in my owning such an exciting successful upcoming producing biomaterial concern. Still very stoked and make no apologies for it.
WAY TO GO KBLB!!!
Tic Tok BAM!!
KBLB
CanItBThisEZ2Make CanItBThisEZ2Make 3 minutes ago
Ha! That’s funny! Let me guess; After 1 MAX makes me a HUGE amount of money another MAX makes me another HUGE amount of money and then I can reload money to the original MAX as he is finally ready to get his company off the ground and some people on here realize that but would prefer to spread Fecal
SRMX
marcis marcis 3 minutes ago
No CEO Erik BluM is a scam period. IMO
Playing all since 2021 here.

What real money is going to use his platforms where he get inside info on you all. LOL

He’s a known manipulator barred from trading
Now a CEO of a trading platform. Okaaay.
SMCE
Nemesis18 Nemesis18 4 minutes ago
>>> I would still bet your real first name is Adam.
NWBO
tweedking tweedking 4 minutes ago
TELL bought out by Woodside $900 m. Stock way up
TGLO
ksquared ksquared 5 minutes ago
Biden delayed dropping out partly because he doubted Kamala Harris’ chances against Trump: report
By Emily Crane Published July 22, 2024, 7:30 a.m. ET
(Hmmm. Maybe he isn't as senile as we think. lol)

President Biden partly delayed dropping his 2024 re-election campai
Jaxxm Jaxxm 6 minutes ago
MAXN has 545 Million outstanding shares, increases every week. Moved to TKLF 42 million os posted net profit
MAXN TKLF
JLPTNG JLPTNG 6 minutes ago
****FOR NEWBIES****


$LWLG issuing more shares - Huge dilution and Lebbys whores liquidating - this company has zero value, no sales, no revenue, HUGE losses - they only way they are here is more dilution - pathetic


3 'Ds" to Lebbys strategy
LWLG
oystersnbeer oystersnbeer 6 minutes ago
https://www.youtube.com/watch?v=tegw25qqbAs

https://www.youtube.com/watch?v=KMWsYJxCK4I

https://qph.cf2.quoracdn.net/main-qimg-a96e7c0550efe46d396f0e8f8d916027
Batman412 Batman412 7 minutes ago
I’ll be happy if it sees 0012 again
TONR
LVerstee LVerstee 7 minutes ago
Then there should be zero delay. That money should be in today and we all should be seeing our funds.
ITUP
CanItBThisEZ2Make CanItBThisEZ2Make 7 minutes ago
BEST SELLERS RANK (BSR) IS 662 15 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value De
SRMX
timberwolf7 timberwolf7 7 minutes ago
Tomorrow morning is going to be one of those 'binary' events in the

baby bio tech world isn't it.
JAGX
HGilS HGilS 9 minutes ago
To all longs - have a wonderful week :-)
Getting closer to the next CC.
Chances of having a PR are getting higher on a daily basis. 5.08% to get a PR
ELTP
Monksdream Monksdream 9 minutes ago
Whoops, I did it, again
HEPA
Midwestrader Midwestrader 10 minutes ago
ROFLMAO!!! Holding short positions?!?!?! This POS CON JOB trades at 0.0001 you dip,how much lower can it go IF anyone was shorting?? Wow...your knowledge of how stock trading works is at a kindergarten level. Anyone spending ten seconds on OTC Markets can see the REAL shorting of any stock which mu
INND
shotsky shotsky 10 minutes ago
Vik has none, Jake was paid off with shares.
NSAV
Awl416 Awl416 10 minutes ago
STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan
SSKN
jedijazz jedijazz 10 minutes ago
$CYCA: Cytta Corp (CYCA) offers CyttaCOMMS incident management system with real-time video & audio streams for ongoing, relevant, actionable intelligence for First Responders. CyttaCARES is a game-changer in ensuring the safety of children in educational institutions and beyond. www.cytta.com #OTCQB
CYCA

Your Recent History

Delayed Upgrade Clock